BCRB 2018

First page Table of contents Previous page 834 Next page Last page

19/09/2018

EGFR as target (Cetuximab) Cetuximab (c225)

The landmark trial

Bonner et al NEJM 2006 Bonner Lancet Oncol 2010

6

Made with FlippingBook - Online catalogs